Survodutide Titration and Appetite Response – Thoughts for a New Compound

Posted by liam_sleepnerd in Weight Loss & Metabolic - 1 points, 0 comments.

I’ve been digging into Survodutide, the dual GLP‑1/Glucagon agonist that’s supposed to cut appetite while ramping up hepatic fat oxidation. 6 mg. For me, the key question is how quickly to bump the dose while watching for nausea or GI upset – the glucagon kick can throw a wrench into the digestive system.

I’ve got HRV and sleep data on my phone, so I’m costes to see if a higher dose dips my HRV or messes with my recovery. I’ve heard anecdotal reports of a 3‑week plateau where weight loss stalls but appetite stays low; that might mean the energy‑expansion part is kicking in and my body is shifting fuel usage. 8 mg) or jump more aggressively?

Also, any data on how much liver‑fat reduction actually shows up in quick imaging or bloodwork? I’m looking to add a variable to my protocol next month, so any practical insights from early real‑world use would help me design a safer titration schedule.

Community discussion - research and educational context only. Not medical advice.